Evidence map›Paper›PMID 29370152›Full record

ArticleMMWR. Morbidity and mortality weekly report2018

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.

Kathleen L Dooling, Angela Guo, Manisha Patel, Grace M Lee, Kelly Moore, Edward A Belongia, Rafael Harpaz

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 308 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
308citing papers in PubMed, 11 pooled it
50.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

308 citing papers in PubMed, 11 syntheses or guidelines pooled it, 594 citations in OpenAlex.

  1. Global herpes zoster burden in adults with COPD: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Immunogenicity and safety of the non-typableHuman vaccines & immunotherapeutics · 2023
    Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

248 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kathleen L Dooling
Angela Guo
Manisha Patel
Grace M Lee
Kelly Moore
Edward A Belongia
Rafael Harpaz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On October 20, 2017, Zoster Vaccine Recombinant, Adjuvanted (Shingrix, GlaxoSmithKline, [GSK] Research Triangle Park, North Carolina), a 2-dose, subunit vaccine containing recombinant glycoprotein E in combination with a novel adjuvant (AS01

Indexed as

Practice Guidelines as TopicAdvisory CommitteesAgedHerpes ZosterHerpes Zoster VaccineHumansImmunization ScheduleImmunocompetenceMiddle AgedUnited StatesUnited States Food and Drug AdministrationVaccines, AttenuatedVaccines, SyntheticHerpes Zoster VaccineVaccines, AttenuatedVaccines, Synthetic

Identifiers

PMID29370152
PMCPMC5812314
OpenAlexW2784682748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.